cbdMD Inc. [AMEX: YCBD] jumped around 0.37 points on Thursday, while shares priced at $2.48 at the close of the session, up 17.54%. The company report on November 5, 2020 that cbdMD Seeks To Obtain Regulatory Approval From United Kingdom’s Regulatory Food Safety Agency (FSA).
cbdMD, Inc. (NYSE American: YCBD, YCBD.PR.A), one of the nation’s leading and most highly trusted and recognized cannabidiol (CBD) brands, confirmed that it is on track to submit its Novel Foods Dossier with the United Kingdom’s Food Safety Agency (FSA) by the required regulatory filing deadline of March 31, 2021.
“By allowing CBD product manufacturers to obtain a Novel Food Authorization from the FSA, the UK is now leading the world in CBD regulation. cbdMD believes it’s in a unique position to demonstrate the safety of its products to the FSA and therefore we believe will be one of the few CBD companies that will be allowed to continue to sell their CBD products on UK’s retail store shelves after the March 31, 2021 deadline. We know that major UK retailers have delayed new CBD product introductions until CBD brands are cleared by the FSA. cbdMD believes if it is successful in obtaining FSA approval, it will have a competitive advantage and therefore a significant opportunity for brand expansion in the UK market. We believe that the expected successful completion of this regulatory approval process provides cbdMD a valuable tool as we continue to prepare for other regulatory approvals around the world,” said Chief Marketing Officer, Ken Cohn.
cbdMD Inc. stock is now 9.73% up from its year-to-date (YTD) trading value. YCBD Stock saw the intraday high of $2.57 and lowest of $2.20 per share. The company’s 52-week high price is 4.10, which means current price is +394.02% above from all time high which was touched on 08/10/20.
Compared to the average trading volume of 787.66K shares, YCBD reached a trading volume of 1431874 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about cbdMD Inc. [YCBD]?
The Average True Range (ATR) for cbdMD Inc. is set at 0.20, with the Price to Sales ratio for YCBD stock in the period of the last 12 months amounting to 3.52. The Price to Book ratio for the last quarter was 1.52, with the Price to Cash per share for the same quarter was set at 0.27.
How has YCBD stock performed recently?
cbdMD Inc. [YCBD] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 14.29. With this latest performance, YCBD shares gained by 25.25% in over the last four-week period, additionally plugging by 161.00% over the last 6 months – not to mention a drop of -35.58% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for YCBD stock in for the last two-week period is set at 60.81, with the RSI for the last a single of trading hit 65.74, and the three-weeks RSI is set at 56.42 for cbdMD Inc. [YCBD]. The present Moving Average for the last 50 days of trading for this stock 2.20, while it was recorded at 2.19 for the last single week of trading, and 1.75 for the last 200 days.
cbdMD Inc. [YCBD]: Deeper insight into the fundamentals
cbdMD Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.00 and a Current Ratio set at 5.50.
Earnings analysis for cbdMD Inc. [YCBD]
With the latest financial reports released by the company, cbdMD Inc. posted 0.79/share EPS, while the average EPS was predicted by analysts to be reported at -0.17/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 564.70%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for YCBD.
Insider trade positions for cbdMD Inc. [YCBD]
There are presently around $13 million, or 11.20% of YCBD stock, in the hands of institutional investors. The top three institutional holders of YCBD stocks are: VANGUARD GROUP INC with ownership of 1,223,882, which is approximately -6.096% of the company’s market cap and around 0.10% of the total institutional ownership; MIRAE ASSET GLOBAL INVESTMENTS CO., LTD., holding 687,257 shares of the stock with an approximate value of $1.7 million in YCBD stocks shares; and BLACKROCK INC., currently with $1.4 million in YCBD stock with ownership of nearly -61.496% of the company’s market capitalization.
26 institutional holders increased their position in cbdMD Inc. [AMEX:YCBD] by around 1,459,574 shares. Additionally, 35 investors decreased positions by around 3,294,054 shares, while 7 investors held positions by with 331,359 shares. The mentioned changes placed institutional holdings at 5,084,987 shares, according to the latest SEC report filing. YCBD stock had 14 new institutional investments in for a total of 575,071 shares, while 19 institutional investors sold positions of 1,240,358 shares during the same period.